NASDAQ: KEQUKewaunee Scientific Revenue
Kewaunee Scientific revenue was $282.00M for the trailing 12 months ending Apr 30, 2026, with -15.6% growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Apr 30, 2026 was $71.4M, up 2.9% from last quarter. For the last reported fiscal year 2026 ending Apr 30, 2026, KEQU annual revenue was $282.0M, with 17.3% growth year-over-year.
KEQU past revenue growth
How has KEQU's revenue growth performed historically?
Company
17.27%
Industry
16.1%
Market
33.39%
KEQU's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KEQU's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KEQU's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
KEQU revenue history
Current Revenue
$282.0M
Current Earnings
$9.6M
Current Profit Margin
3.4%
KEQU's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when KEQU announces revenue.
KEQU Revenue History By Year
| KEQU Yearly Revenue | KEQU Revenue | KEQU Change | KEQU Revenue Growth |
|---|---|---|---|
| 2026-04-30 | $282.00M | $41.53M | +17.27% |
| 2025-04-30 | $240.47M | $36.72M | +18.02% |
| 2024-04-30 | $203.76M | -$15.74M | -7.17% |
| 2023-04-30 | $219.49M | $50.62M | +29.98% |
| 2022-04-30 | $168.87M | $21.40M | +14.51% |
| 2021-04-30 | $147.47M | -$71.00k | -0.05% |
| 2020-04-30 | $147.54M | $990.00k | +0.68% |
| 2019-04-30 | $146.55M | -$11.50M | -7.28% |
| 2018-04-30 | $158.05M | $19.49M | +14.07% |
| 2017-04-30 | $138.56M | $9.93M | +7.72% |
| 2016-04-30 | $128.63M | $9.80M | +8.25% |
| 2015-04-30 | $118.83M | $7.66M | +6.89% |
| 2014-04-30 | $111.17M | -$5.96M | -5.08% |
| 2013-04-30 | $117.12M | $14.27M | +13.88% |
| 2012-04-30 | $102.85M | $2.84M | +2.84% |
| 2011-04-30 | $100.00M | $910.00k | +0.92% |
| 2010-04-30 | $99.09M | -$4.89M | -4.70% |
| 2009-04-30 | $103.98M | $14.47M | +16.16% |
| 2008-04-30 | $89.51M | $8.07M | +9.91% |
| 2007-04-30 | $81.44M | -$2.63M | -3.13% |
| 2006-04-30 | $84.07M | $10.59M | +14.41% |
| 2005-04-30 | $73.48M | -$21.22M | -22.41% |
| 2004-04-30 | $94.70M | $23.54M | +33.07% |
| 2003-04-30 | $71.16M | -$13.69M | -16.13% |
| 2002-04-30 | $84.85M | $7.79M | +10.11% |
| 2001-04-30 | $77.06M | $2.26M | +3.02% |
| 2000-04-30 | $74.80M | -$2.68M | -3.46% |
| 1999-04-30 | $77.48M | $4.44M | +6.08% |
| 1998-04-30 | $73.04M | $11.08M | +17.88% |
| 1997-04-30 | $61.96M | $4.40M | +7.65% |
| 1996-04-30 | $57.56M | -$4.92M | -7.87% |
| 1995-04-30 | $62.48M | -$3.59M | -5.44% |
| 1994-04-30 | $66.07M | -$916.00k | -1.37% |
| 1993-04-30 | $66.98M | N/A | N/A |
Kewaunee Scientific Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.